Analgesia and sedation in hemodynamic unstable patient by Višnja Majerić Kogler et al.
10 www.signavitae.com
Analgesia and sedation 
in hemodynamic unstable 
patient
ABSTRACT
Pain, restlessness, tension and delirium are almost always encountered while treating hemodynamic unstable critical 
patients in the intensive care units. Usually in critical patients, the evaluation of the nature and pain intensity (VAS scale) are 
often impossible. During the last 10 years intense nociceptor somatic and visceral post operative pain is believed to be the 
most crucial factor in the development of endocrine and neurohumoral disorders, within the postoperative period. Chronic 
post operative pain is appearing often (30%-40%), with great influence on the quality of patients life. The modern principal 
in treating acute pain is the use of multimodal balanced analgesia approach, which is individually catered with drug and 
dose for each patient. Modern systemic analgesia is understood to be the continuous use of opiates or opioids, titrated 
towards pain intensity, with a minimum number of complications even in hemodynamic unstable patients. The combined 
use of opioids with NSAID and paracetamol reduces the overall dosage of opioids by 20% - 30% and therefore significantly 
contributes to hemodynamic and respiratory stability. Effective and safe epidural analgesia in hemodynamic unstable 
patients can be optimized by simultaneous use of various drugs with different mechanisms of action (local anaesthetic, 
opioid, adrenalin, ketamin). The accepted concept of analgosedation in critical patients is understood to be the use of 
short acting drugs (fentanyl, sufentanil, remifentanil, midazolam, propofol) in which drug dosage can be quickly adjusted 
in respect to the present clinical state of the patient.
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Introduction
Pain, restlessness, tension, and delir-
ium are almost always encountered 
while treating hemodynamic unstable 
critical patients in the intensive care 
unit. Due to the critical state of these 
patients, symptoms are often masked 
and are difficult to observe and are 
often underestimated, not completely 
and without efficacy treated.
 During the last 10 years intense nocice-
ptor somatic and visceral post operative 
pain is believed to be the most crucial 
factor in the development of endocrine 
and neurohumoral disorders, within 
the postoperative period.  Therefore, 
this period is marked by an increase 
in catabolism, increased secretions of 
stress hormones, increased stress on 
the cardiovascular system, pulmonary 
function disorders, hyper coagulative 
states, decreased fibrinolysis, immu-
nosupression, paralytic ileus, and post 
operative nausea and vomiting. The 
effects of the previously mentioned 
events lead to a dysfunction in the 
homeostasis of glucose, lipid and pro-
tein metabolism. 
The intensity and persistence of these 
dysfunctions depends upon the inten-
sity of surgical injuries, effectiveness 
of treating post operative pain, and 
the use of numerous methods which 
can speed up rehabilitation of patients. 
(1,2)
A particular problem is the inadequate 
effectiveness in controlling the dynamic 
and static pain during thoracic surgery 
and the development of chronic pain 
syndrome with central and peripheral 
sensitization within the upper abdomen. 
Chronic post operative pain appearing 
often, with great influence on the qual-
ity of life in patients, is very high and 
accounts for about 40% of patients.  
Usually in critical patients, the evalua-
tion to the nature and intensity of pain 
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(VAS patient information) are often 
impossible.  In the assessment of pain 
intensity we often rely on physiological 
clues, the development of restlessness, 
vegetative clues, and facial mimicry 
and expression (faces scale).  
The modern principle in treating acute 
pain is with the use of a multimodal 
balanced analgesia approach, which is 
individually catered with drug and dose 
for each patient.
Systemic drug use
Modern systemic analgesia is under-
stood to be the continuous use of 
opiates or opioids, titrated towards 
pain intensity, with minimal effects on 
patient mobilization and with a mini-
mum number of complications.  The 
therapeutic goals are to reach enough 
analgesia and patient comfort. 
Opiates and opioids remain the corner-
stone in treating intense postoperative 
pain even in hemodynamic unstable 
patients.  However, over generalized 
treatment plans in prescribing drugs 
and inadequate individualization for 
each patient are often the reasons for 
developing cardiorespiratory complica-
tions and drug overdoses. (3,4)
Systemic intramuscular drug treatments 
due to the unpredictable speed of 
absorption, unknown start and length of 
effectiveness, as well as patient discom-
fort, are not applied in critically patients. 
The most frequently used opiate anal-
gesics within the intensive care unit are 
morphine, fentanyl, and sufentanyl.
In the hemodynamic unstable patient 
the recommended dosage of fenta-
nyl as a bolus is 25 – 100μ g every 5 
– 15 minutes until reaching the desired 
analgesic effect.  Due to the short drug 
half life, a continuous infusion is recom-
mended at 0,0125-0,1mg/h, thereafter.
The advantages of fentanyl over mor-
phine are the reduced release of hista-
mine and its elimination which is inde-
pendent of the kidneys.
Bolus dose of sufentanyl is 0,01-0,05mg 
and 0,01-0,05 mg/h for continuous infu-
sion.
Morphine intravenously causes addi-
tional vasodilatation and hypotension, 
due to the release of histamine.  The 
effects in patients with damaged liver 
and kidney functions are pronounced 
and prolonged.  The bolus dosage in 
hemodynamic unstable patients is 1 – 2 
mg i.v. every 5 – 15 min. until reaching 
desired effects, and then there 0,01-
0,10 mg/kg i.v. every 1 – 2 h.
When using patient controlled analge-
sia (PCA) in the hemodynamic unstable 
patient it is important to set the mor-
phine limit at 1 mg at a lockout interval 
of 5 – 10 minutes.  The usual PCA dose 
of fentanyl is 10 – 20 μg, at a lockout 
interval of 5-10 minutes.
The combined use of NSAID’s and 
paracetamol, as long as there are no 
contraindications of usage, it is pos-
sible to achieve adequate analgesia 
for moderate pain using dosages of 
paracetamol (1 g per os every 6 hours 
for adults or 2 g rectal, and in children 
40 mg/kg bolus then 20 mg/kg every 6 
hours per os).
The combined use with opioids reduc-
es the overall dosage of opiods used, 
by 20 – 30 %, and therefore significantly 
contributes to hemodynamic and respi-
ratory stability. (5)
Non-opioid analgesic protocols which 
perform additively or synergistically with 
opiates and opioids are the following:
• Diclofenac 50 mg / 8 h i.v., orally, or 
rectally
• Ketoprofen 100 mg / 8 h i.v., orally, 
or rectally
• Ketorolac 10 – 30 mg / 8 h i.v. or 
orally
• Ibuprofen 400 mg / 8 h orally or rec-
tally
In geriatric patients, the need for the 
use of opiates and opioids (morphine, 
fentanyl) are reduced two to four times, 
in effectively treating acute pain.  The 
reduced requirements are unexplain-
able, except for the physiological 
changes that occur in older life years, 
rather than important pharmacological 
dynamic components.
In patients older than 75 years of age, 
the drug half life of tramadol is greatly 
increased, which greatly reduces the 
daily dosage requirements.
Kidney dysfunction increases risks of 
active metabolite build up of morphine 
– 6, morphine – 3 – glucorinide, nor-
moperidine, hydromorphone – 3 – glu-
curonide and O desmethyltramadol. (6)
In geriatric patients, the reduction of 
nausea, vomiting and pruritus has been 
observed. 
Reduced states of confusion and less 
cognitive dysfunction have been noted 
with the use of fentanyl, rather than with 
morphine.
Epidural analgesia
Thoracic epidural analgesia (TEA) 
dilates constricted coronary arteries, 
increases myocardial oxygenation, 
reduces cardiac oxygen consumption, 
reduces frequent ischemic coronary 
incidences, improves pulmonary oxy-
genation and overall function, and also 
positively influences bowel motility.
Lumbar epidural analgesia leads to the 
dilation of arteries in the lower half of 
the body, constricts coronary arteries, 
decreases myocardial oxygen delivery, 
does not improve bowel motility, and 
often leads to urinary retention.
From the above mentioned, it is clear 
to see that lumbar epidural analgesia 
can increase the risk of occurrence of 
coronary incidences.
Most authors mention the use of small 
volume amounts of 4 – 6 ml / h of local 
anesthetics, which will keep favorable 
hemodynamic stability.  Perioperative 
factors which reduce venous return 
such as hypovolemia and vena cava 
compression require quick correction 
of hypotension with intravenous fluid 
volumes.  Venous dilation, the result of 
remarkable hypotension can be reduced 
with the use of alpha 1 agonists, ephe-
drine or dopamine at a dose of 4 – 8 
μg / kg / min.  In patients being treated 
for hypertension and ischemic heart 
disease caution is necessary.  Patients 
on ACE inhibitors, the hypotensive 
effects are great and prolonged.  Posi-
tive hemodynamic outcome and mod-
erate sympathic blockade of cardiac 
nerve segments (T3 – T5) results in the 
decrease of after load.  TEA can reduce 
compensatory increases of heart rate 
with the appearance of hypovolemia. 
Patients with unstable angina pectoris, 
TEA (T1 – T5) greatly eases the pain 
suffered in angina attacks while main-
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taining minute heart volume, systemic 
vascular resistance, and coronary per-
fusion pressure.
Effective and safe epidural analgesia in 
hemodynamic unstable patients can be 
optimized by simultaneous use of vari-
ous drugs with different mechanisms of 
action (a multimodal action principle).
Brevik recommends for an optimal and 
safe combination to use a mixture of 
bupivacaine 1 mg/ml, fentanyl 2 micro-
gram/ml, and adrenalin 2 microgram/ml. 
The sub anesthetic dose of bupivacaine 
inhibits excitatory synaptic mechanisms 
in specific areas of the spinal cord, while 
fentanyl and adrenalin inhibit pre and 
post synaptic opioid and alpha 2 adren-
ergic receptors in the posterior horn, 
of the spinal cord. Documented syn-
ergism using such combinations ena-
bles significant reductions of individual 
drug dosages, while achieving maximal 
results and minimal side effects.
Sufentanil is more potent than fentanyl 
it is well documented and approved for 
epidural administration.
Ropivacain is a good alternative to bupi-
vacain and levobupivacain for hemody-
namic instable patients because is less 
cardiotoxic.   
Not only does adrenalin provide anal-
gesic effects, but it also slows down 
systemic absorption of fentanyl and 
bupivacine, reducing their systemic 
side effects. (7)
Sedation
Drugs most often used in influencing 
the level of consciousness and memory 
are:
Analgesics: Morphine, Fentanyl, Peti-
din, Sufentanil, Remifentanil, Alfentanil




The accepted concept of analgoseda-
tion in critical patients is understood to 
be the use of short acting drugs (fenta-
nyl, sufentanil, remifentanil, midazolam, 
propofol) in which drug dosage can 
be quickly adjusted in respect to the 
present clinical state of the patient.  This 
provides the possibility of therapeutic 
intervention, and as necessary the abil-
ity to neurologically assess the state of 
the patient.
Routine guidelines of fixed drug combi-
nations, used continuously (midazolam, 
fentanyl) cause drug accumulation and 
overdoses, dangerous side effects 
(respiratory depression, hypotension) 
and prolonged awakening.
Benzodiazepines
The most regularly used benzo-
diazepines in critical patients are 
diazepam, midazolam, and lorazepam.
The effective bolus dose of diazepam 
of 2 – 6 mg can be repeated after 2 
– 5 minutes.  Repeating diazepam in 
boluses every 5 – 15 minutes provides 
effective sedation of agitated patients. 
Unfortunately, due to the lengthy drug 
half life, patients with liver and kidney 
dysfunction, sedation is prolonged, 
as well as unpredictable in duration. 
Therefore, continuous infusions are not 
recommended.
Midazolam boluses of 2 – 5 mg cause 
quick sedations of short length, but 
hemodynamic instability are often una-
voidable.  Using continuous infusions 
for longer than 48 – 72 hours, critical 
patients are unpredictable for emer-
gence, especially when hypo albu-
minemia and renal insufficiency are 
present. 
Lorazepam boluses of 1 – 4 mg every 
2 – 6 hours are favorable for long term 
sedation, since it is not lipid soluble 
and does not produce active metabo-
lites.  Due to the slow appearance of 
therapeutic effects, it is not possible to 
achieve a rapid response.  However, 
recommendation from the Society for 
Critical Care (2002) is to use lorazepam, 
as the sedative of choice, in long term 
sedation of critical patients. 
Propofol due to its speedy effects (1 – 2 
minutes) and short duration of action (2 
– 8 min) is effective in controlling acute 
agitation, and in instances when expe-
dite awakening is necessary.  However, 
due to the possibility of significant hypo-
tension and myocardial depression it is 
not favorable for the sedation of hemo-
dynamic unstable patients.  Elevated 
doses of continuous infusions (>75μg / 
kg / min) can cause metabolic acidosis, 
serious arrhythmias, and heart failure.
The use of remifentanil in small doses 
with midazolam or propofol, also known 
as analgesia basis sedation, has pro-
vided acceptable analgesia and patient 
comfort.  In addition, adequate hemo-
dynamic stability, duration of analgo-
sedation, predictability of awakening, 
and fewer side effects have also been 
observed. (8)
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